Drug maker Glenmark Generics Ltd, a subsidiary of Glenmark Pharmaceuticals Ltd, expects to raise up to Rupees 570 crore through its IPO for funding loans and general corporate purposes.The company, which filed the draft red herring prospectus with market regulator SEBI on September 30, is mulling a pre-IPO placement worth Rs 100 crore.